-
公开(公告)号:AU2004205494A1
公开(公告)日:2004-08-05
申请号:AU2004205494
申请日:2004-01-20
Applicant: UCB FARCHIM SA
Inventor: ATES CELAL , CAVOY EMILE , BOUVY DIDIER
IPC: C07D201/00 , C07D271/06 , C07D271/07 , C07D295/15 , C07D295/14
Abstract: The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
-
公开(公告)号:CA2599498C
公开(公告)日:2011-06-21
申请号:CA2599498
申请日:2006-02-23
Applicant: UCB FARCHIM SA
Inventor: PALACIO MAGALI , ATES CELAL
IPC: C07D295/088 , C07D207/28
Abstract: The present invention relates to (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide - (S)-pyrrolidone-5-carboxylic acid salt; (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide - (S)-pyrrolidone-5-carboxylic acid salt; (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide - (R)-pyrrolidone-5-carboxylic acid salt; or (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxycetamide - (R)-pyrrolidone-5-carboxylic salt. The present invention relates also to a process for preparing (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide (I) and (R)-2-[4-(4-chlorobenzhydryl) piperazin-1-yl]-ethoxyacetamide (II) by chemical resolution of a mixture. These compounds are respectively intermediates for the synthesis of dextrocetirizine and levocetirizine.
-
公开(公告)号:NO20053910D0
公开(公告)日:2005-08-22
申请号:NO20053910
申请日:2005-08-22
Applicant: UCB FARCHIM SA
Inventor: ATES CELAL , CAVOY EMILE , BOUVY DIDIER
IPC: C07D201/00 , C07D271/06 , C07D271/07 , C07D295/15 , C07D
Abstract: The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
-
公开(公告)号:ES2326689T3
公开(公告)日:2009-10-16
申请号:ES06707220
申请日:2006-02-23
Applicant: UCB FARCHIM SA
Inventor: PALACIO MAGALI , ATES CELAL
IPC: C07D295/088 , C07D207/28
Abstract: Un compuesto seleccionado de sal de ácido (S)-2-[4-(4-clorobencidril)piperazin-1-il]-etoxiacetamida-(S)-pirrolidona-5-carboxílico; sal de ácido (R)-2-[4-(4-clorobencidril)piperazin-1-il]-etoxiacetamida-(S)-pirrolidona-5-carboxílico; sal de ácido (S)-2-[4-(4-clorobencidril)piperazin-1-il]-etoxiacetamida-(R)-pirrolidona-5-carboxílico; o sal de ácido (R)-2-[4-(4-clorobencidril)piperazin-1-il]-etoxiacetamida-(R)-pirrolidona-5-carboxílico.
-
公开(公告)号:CA2599498A1
公开(公告)日:2006-09-14
申请号:CA2599498
申请日:2006-02-23
Applicant: UCB FARCHIM SA
Inventor: ATES CELAL , PALACIO MAGALI
IPC: C07D295/088 , C07D207/28
Abstract: The present invention relates to (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(R)-pyrrolidone-5-carboxylicacid salt; or (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxycetamide-(R)-pyrrolidone-5-carboxylic salt. The present invention relates also to a process for preparing (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide (I) and (R)-2-[4-(4-chlorobenzhydryl) piperazin-1-yl]-ethoxyacetamide (II) by chemical resolution of a mixture. These compounds are respectively intermediates for the synthesis of dextrocetirizine and levocetirizine.
-
公开(公告)号:NO20053910A
公开(公告)日:2005-10-21
申请号:NO20053910
申请日:2005-08-22
Applicant: UCB FARCHIM SA
Inventor: ATES CELAL , CAVOY EMILE , BOUVY DIDIER
IPC: C07D201/00 , C07D271/06 , C07D271/07 , C07D295/15 , C07D295/14 , A61K31/495
CPC classification number: C07D271/07 , C07D295/15
-
公开(公告)号:NO330989B1
公开(公告)日:2011-08-29
申请号:NO20053910
申请日:2005-08-22
Applicant: UCB FARCHIM SA
Inventor: ATES CELAL , CAVOY EMILE , BOUVY DIDIER
IPC: C07D295/15 , C07D201/00 , C07D271/06 , C07D271/07
Abstract: The present invention relates to new enantiomerically pure piperazine derivatives of formula (I) wherein Y represents hydroxy or a leaving group and n is 1, 2, 3, 4 or 5, and to their use as synthesis intermediates, especially for the preparation of pharmaceutically active compounds
-
公开(公告)号:EA014248B1
公开(公告)日:2010-10-29
申请号:EA200900359
申请日:2006-02-23
Applicant: UCB FARCHIM SA
Inventor: PALASCIO MAGALI , ATES CELAL
IPC: C07D295/088 , C07D207/28
Abstract: Визобретенииописанысоль (S)-2-[4-(4-хлорбензгидрил)пиперазин-1-ил]этоксиацетамидас (S)-пирролидон-5-карбоновойкислотой; соль (R)-2-[4-(4-хлорбензгидрил)пиперазин-1-ил]этоксиацетамидас (S)-пирролидон-5-карбоновойкислотой; соль (S)-2-[4-(4-хлорбензгидрил)пиперазин-1-ил]этоксиацетамидас (R)-пирролидон-5-карбоновойкислотойи соль (R)-2-[4-(4-хлорбензгидрил)пиперазин-1-ил]этоксиацетамидас (R)-пирролидон-5-карбоновойкислотой. Визобретениитакжеописанспособполучения (S)-2-[4-(4-хлорбензгидрил)пиперазин-1-ил]этоксиацетамида (I) и (R)-2-[4-(4-хлорбензгидрил)пиперазин-1-ил]этоксиацетамида (II) путемхимическогоразделениясмеси. Этисоединенияявляютсяпромежуточнымипродуктамидлясинтезадекстроцетиризинаи левоцетиризинасоответственно.
-
公开(公告)号:NZ556580A
公开(公告)日:2009-08-28
申请号:NZ55658006
申请日:2006-02-23
Applicant: UCB FARCHIM SA
Inventor: PALACIO MAGALI , ATES CELAL
IPC: C07D295/088 , C07D207/28
Abstract: The disclosure relates to (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(S)-pyrrolidone-5-carboxylic acid salt; (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide-(R)-pyrrolidone-5-carboxylic acid salt; or (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxycetamide-(R)-pyrrolidone-5-carboxylic salt. The disclosure also relates to a process for preparing (S)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide (I) and (R)-2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide (II) by chemical resolution of a mixture. These compounds are respectively intermediates for the synthesis of dextrocetirizine and levocetirizine.
-
公开(公告)号:MX2007010455A
公开(公告)日:2007-11-08
申请号:MX2007010455
申请日:2006-02-23
Applicant: UCB FARCHIM SA
Inventor: PALACIO MAGALI , ATES CELAL
IPC: C07D295/088 , C07D207/28
Abstract: La presente invencion se relaciona con la sal de acido (S)-2-[4-[4- clorobenzhidril)piperazin-1-il]-etoxiacetamida-(S)-pirrolidona- 5-carboxilico, sal de acido (R)-2-[4-[4-clorobenzhidril) piperazin-1-il]-etoxiacetamida-(S)- pirrolidona-5-carboxilico, sal de acido (S)-2-[4-[4-clorobenzhidril)piperazin-1-il]- etoxiacetamida-(R)- pirrolidona-5-carboxilico, sal de acido (R)-2-[4-[4-clorobenzhidril)piperazin-1-il]-etoxiacetamida-(R)- pirrolidona-5-carboxilico. La presente invencion se relaciona tambien con un proceso para preparar (S)-2-[4-[4-clorobenzhidril) piperazin-1-il]-etoxiacetamida-(I) y (R)-2-[4-[4-clorobenzhidril) piperazin-1-il]-etoxiacetamida-(II) por la resolucion quimica de una mezcla. Estos compuestos son compuestos intermediarios respectivamente para la sintesis de la dextrocetirizina y levocetirizina.
-
-
-
-
-
-
-
-
-